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Abstract
Background Takotsubo cardiomyopathy (TCC) is a tran-
sient condition characterised by severe left ventricular dys-
function combined with symptoms and signs mimicking
myocardial infarction. Emotional triggers are common, but
little is known about the psychological background charac-
teristics of TCC. This study examined whether patients with
TTC have higher levels of psychological distress (depres-
sive symptoms, perceived stress, general anxiety), illness-
related anxiety and distinct personality factors compared
with healthy controls and patients with heart failure.
Methods and Results Patients with TCC (N = 18; mean
age 68.3 ± 11.7 years, 77.8 % women) and two comparison
groups (healthy controls: N = 19, age 60.0 ± 7.6, 68.4 %
women and patients with chronic heart failure: N = 19, age
68.8 ± 10.1, 68.4 % women) completed standardised ques-
tionnaires to measure depression (PHQ-9), perceived stress
(PSS-10), general anxiety (GAD-7), illness-related anxiety
(WI-7) and personality factors (NEO-FFI and DS-14). Psy-
chological measures were obtained at 23 ± 18 months fol-
lowing the acute TTC event. Results showed that patients
with TCC had higher levels of depressive symptoms (5.2 ±
5.2 vs. 2.5 ± 2.4, p = 0.039) and illness-related anxiety
(2.1 ± 1.7 vs. 0.7 ± 1.3, p = 0.005) compared with healthy
controls. Patients with TCC did not display significantly el-
evated perceived stress (p = 0.072) or general anxiety (p =
 W.J. Kop
w.j.kop@uvt.nl
1 Department of Medical and Clinical Psychology, Center
of Research on Psychology in Somatic diseases (CoRPS),
Tilburg University, Tilburg, The Netherlands
2 Department of Cardiology, Elisabeth-TweeSteden Hospital,
Tilburg, The Netherlands
0.170). Regarding personality factors, levels of openness
were lower in TCC compared with healthy controls (34.2 ±
4.3 vs. 38.2 ± 5.6, p = 0.021). No differences between
TCC and heart failure patients were found regarding the
psychological measures.
Conclusions TCC is associated with higher levels of de-
pressive symptoms, more illness-related anxiety and less
openness compared with healthy controls. These data sug-
gest that TCC is associated with adverse psychological fac-
tors that may persist well after the acute episode.
Keywords Tako-Tsubo cardiomyopathy · Depression ·
Anxiety · Personality · Psychological distress · Apical
ballooning syndrome
Introduction
Takotsubo cardiomyopathy (TCC) is increasingly recog-
nised in clinical cardiology [1–4] and is characterised by
severe left ventricular dysfunction, typically with apical
ballooning, combined with symptoms mimicking myocar-
dial infarction [5]. This transient condition usually presents
with symptoms including chest pain and/or dyspnoea with
ST-segment elevation or T-wave inversion, and the absence
of obstructive coronary artery disease [1]. Unique to this
syndrome is the high prevalence of emotional triggers pre-
ceding the onset of event [1, 2, 6, 7] with estimates rang-
ing from 26–47 %, compared with physical precipitants in
8–50 % [8–13]. Among the psychological triggers are news
of an unexpected death, experiencing fear, and other events
that result in intense emotional experiences [2, 14]. TCC
was first introduced in the Japanese scientific literature by
Sato, Dote and their colleagues in 1990 and the first Eng-
lish-language publications date back to 2000. Multiple
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terms (over 70) have been used to describe this syndrome,
including the typical left ventricular abnormality (e.g., api-
cal ballooning syndrome) and the characteristic psycholog-
ical precipitants (e.g., stress cardiomyopathy), but it has
been argued that TCC is the most appropriate name for this
condition [15].
The high prevalence of emotional triggers in TCC sug-
gests that some individuals are particularly vulnerable to
experiencing psychological distress that may result in this
syndrome. The prevalence of depression and anxiety disor-
ders in TCC ranges from 21–60 % [1, 16–19]. An increase
in levels of psychological distress from admission to one-
year follow-up is common [20]. Few studies have obtained
a comprehensive assessment of psychological measures of
distress in patients with TCC.
Illness-related anxiety and related constructs such as
hypochondriasis are of particular relevance to TCC because
of the unpredictable nature of this syndrome. No studies
have evaluated illness-related anxiety or hypochondriasis in
TCC. In addition, these distress-related measures have not
been studied in the context of patients’ personality factors.
Stable personality factors may contribute to individual dif-
ferences in emotional well-being, responses to distressing
factors and cardiovascular reactivity to emotional stress
[14].
This study tested whether patients with a clinical history
of TCC display higher levels of depressive symptoms, per-
ceived stress and general anxiety and illness-related anxiety
compared with healthy controls and patients with chronic
heart failure (HF). In addition, we examined whether per-
sonality factors play a role in the hypothesised elevated
levels of depression, psychological distress and anxiety in
TCC patients versus controls. Investigating the psycho-
logical correlates of TCC could be useful in optimising
patient risk stratification and elucidating the pathophysio-
logical processes involved [14].
Methods
Study sample
Between January 2012 and April 2014, 56 patients (18 TCC
patients, 19 HF patients and 19 healthy controls) partici-
pated in the study. A previous report based on this study
addressed the neurohormonal and haemodynamic responses
in TCC [22]. The diagnosis was based on 1) akinesia or
dyskinesia of the apical and/or mid-ventricular segments of
the left ventricle with regional wall motion abnormalities
that extend beyond the distribution of a single epicardial
vessel; 2) signs and symptoms suggesting acute coronary
syndrome (i.e., new-onset ECG abnormalities such as ST-
segment elevation and/or T-wave inversion, modest eleva-
tion in cardiac troponin levels, and/or typical angina symp-
toms); and 3) absence of obstructive coronary artery dis-
ease, pheochromocytoma or myocarditis that could account
for the condition [1]. TCC patients were identified by re-
view of the electronic medical records over the past 5 years
(between 2009 and 2014). Patients were not included if
TCC occurred in response to surgery or acute injury. The
mean time between the acute event and study participation
was 23 ± 18 months (median = 23, IQR = 3–40 months).
A control group of patients with stable HF (NYHA
class I–II) without a history of TCC was recruited from
the same hospital. This HF control group was used to
examine the role of compromise in left ventricular function
combined with minimal or no symptoms compared with
the normal left ventricular function in TCC. A second con-
trol group consisted of healthy women and men who were
recruited by advertisement. The healthy controls were re-
quired not to have a history of TCC, HF or coronary artery
disease.
Exclusion criteria for all participants were: 1) age >85
years, 2) current active treatment for cancer or another life-
threatening condition, 3) currently on hormone replacement
therapy, and 4) cognitive impairment interfering with com-
pletion of questionnaires. The study was conducted at the
Elisabeth-TweeSteden Hospital, Tilburg, the Netherlands.
The protocol was approved by the Institutional Review
Board (#NL35988.008.11). All participants provided in-
formed consent prior to participating.
Measurements
Depression: Depressive symptoms were assessed using the
Patient Health Questionnaire (PHQ-9) [23]. The items as-
sess the standard criteria for major depressive disorder, with
higher scores indicating higher levels of depression. A cut-
off score of ≥10 indicates a moderate to severe level of de-
pression symptoms. The internal consistency of the PHQ-9
is excellent (Cronbach’s α = 0.89).
Perceived stress: The Perceived Stress Scale (PSS) is
designed to measure the degree to which situations in one’s
life are appraised as stressful [24]. The 10-item version
shows better psychometric characteristics in comparison
with the original 14-item scale [26] with good reliability
characteristics (Cronbach’s α = 0.85) [25].
General anxiety: The 7-item General Anxiety Disorder
(GAD-7) scale was used to measure anxiety symptoms [26].
The GAD-7 has excellent internal consistency (Cronbach’s
α = 0.92).
Illness-related anxiety: Illness-related anxiety was as-
sessed using the Whiteley-7 scale. This questionnaire as-
sesses illness-related worries and beliefs and is valid for the
evaluation of illness-related anxiety and hypochondriasis in
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Female 14 (77.8 %) 13 (68.4 %) 0.522 13 (68.4 %) 0.522
Age 68.3±11.7 68.8±10.1 0.888 60.0±7.6 0.014
Married 11 (61.1 %) 14 (77.8 %) 0.278 14 (73.7 %) 0.414
Children 15 (83.3 %) 17 (94.4 %) 0.289 15 (78.9 %) 0.734
Higher education 3 (16.7 %) 2 (11.8 %) 0.679 8 (42.1 %) 0.091
Employed 3 (16.7 %) 3 (16.7 %) >0.999 13 (68.4 %) 0.001
Smoking status 3 (16.7 %) 5 (27.8 %) 0.423 0 (0.0 %) 0.063
Alcohol use 11 (61.1 %) 8 (44.4 %) 0.317 16 (84.2 %) 0.114
BMI (kg/m2) 26.19±5.1 29.64±5.2 0.053 26.00±3.9 0.898
Medical history
Atrial fibrillation 1 (5.6 %) 3 (15.8 %) 0.316 0 (0.0 %) 0.298
Hypertension 15 (83.3 %) 17 (89.5 %) 0.585 6 (31.6 %) 0.001
Hypercholesterolaemia 8 (44.4 %) 12 (63.2 %) 0.254 3 (15.8 %) 0.057
Diabetes 1 (5.6 %) 9 (47.4 %) 0.004 0 (0.0 %) 0.298
Stroke 1 (5.6 %) 1 (5.6 %) >0.999 0 (0.0 %) 0.298
COPD 1 (5.6 %) 4 (22.2 %) 0.148 0 (0.0 %) 0.298
Cancer 4 (22.2 %) 4 (25.0 %) 0.849 2 (10.5 %) 0.335
Kidney or liver disease 2 (11.1 %) 1 (5.9 %) 0.581 0 (0.0 %) 0.135
Stomach ulcer 2 (11.1 %) 0 (0 %) 0.146 0 (0.0 %) 0.135
Medication
Beta-blockers 12 (75.0 %) 14 (87.5 %) 0.365 3 (15.8 %) <0.001
ACE-inhibitors 11 (61.1 %) 15 (78.9 %) 0.235 1 (5.3 %) <0.001
Diuretics 4 (22.2 %) 16 (84.2 %) <0.001 3 (15.8 %) 0.618
Vasodilators 1 (6.3 %) 8 (50.0 %) 0.006 0 (0.0 %) 0.269
Antiplatelet 13 (76.5 %) 16 (100 %) 0.038 1 (5.3 %) <0.001
Lipid lowering 7 (41.2 %) 10 (62.5 %) 0.221 2 (10.5 %) 0.034
Antidepressants 1 (6.3 %) 2 (12.5 %) 0.544 0 (0.0 %) 0.269
Benzodiazepine 2 (12.5 %) 2 (12.5 %) >0.999 0 (0.0 %) 0.112
TCC takotsubo cardiomyopathy, HF heart failure, BMI body mass index, COPD chronic obstructive pulmonary disease.
medical settings. The internal consistency of the WI-7 is
moderate (Cronbach’s α = 0.68) [27].
Personality factors: Personality factors were assessed us-
ing the NEO Five-Factor Inventory (NEO-FFI) [28] and the
DS-14 for type-D personality [29]. The NEO-FFI [28] as-
sesses the ‘Big-5’ personality dimensions: neuroticism, ex-
traversion, openness, conscientiousness and agreeableness.
The reliability of the NEO-FFI is acceptable to good (Cron-
bach’s α values ranging from 0.69 to 0.86).
The DS14 assesses the distressed personality type
(Type D) and consists of two 7-item subscales: nega-
tive affectivity and social inhibition. The DS14 has a high
internal consistency (Cronbach’s α = 0.88 and 0.86 for the
two subscales, respectively) [29]. Continuous scores were
used to assess the negative affect and social inhibition di-
mensions. The interaction between the negative affectivity
and social inhibition subscales, based on the product of
the subscale z-scores, was used as the primary measure of
type D. In addition, the previously validated cut-off score ≥
10 on both subscales was used to classify the presence or
absence of type D personality to enable comparisons with
other studies [21, 29].
Statistical analyses
Data are presented as mean ± standard deviation or N and
percentages as appropriate. The square root of the raw
values for the PHQ-9, GAD-7 and WI-7 was used to limit
bias related to non-normal distribution of the data prior
to statistical analyses. The PHQ-9 was also dichotomised
using the clinical cut-off value ≥ 10 [23].
Differences between the TCC patients and both control
groups were examined using independent samples t-tests
and χ2 tests. Multivariate analysis of variance (MANOVA)
was used to examine differences between TCC and the
control groups on the combined set of psychological de-
pendent variables (using general linear models). The final
MANOVA models involved analyses adjusted for age and
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Fig. 1 Differences in depressive symptoms, perceived stress, general
anxiety and illness-related anxiety between TTC patients, HF patients
and healthy controls
sex and examined whether group differences in depressive
symptoms, perceived stress and anxiety remained signif-
icant when adjusting for stable personality factors. Data
were analysed using SPSS (version 22.0) and a two-sided
p-value of <0.05 was considered statistically significant.
Results
Characteristics of the study sample are shown in Table 1.
TCC patients were on average older compared with the
healthy control group (68.3 ± 11.7 vs. 60.0 ± 7.6 years,
p = 0.014) and less likely to be employed. A history of
clinical depression was present in 6 (33 %) TCC patients,
compared with 4 (21 %) in the healthy control group and 6
(32 %) in the HF group (p = 0.837). Consistent with the in-
clusion criteria, left ventricular ejection fraction was normal
in TCC (63.6 ± 7.5 %) and healthy controls (64.5 ± 7.5 %)
and reduced in the HF control group (38.3 ± 15.4 %). Pa-
tients with TCC were more likely to have hypertension and
use medications (beta-adrenergic blocking agents, ACE in-
hibitors, antiplatelet medications, and lipid-lowering drugs)
compared with healthy controls (Table 1).
A triggering event related to the onset of TCC was re-
ported in 10/18 (56 %) patients with TCC: 8 patients had an
emotional trigger, and 2 patients reported a physical trigger
combined with psychological distress, 1 patient could not
remember the precipitating circumstances, and 7 patients
had no clear triggering pre-TCC event.
Depression, perceived stress and general anxiety as
related to TCC
As shown in Fig. 1, TTC patients reported higher levels of
depressive symptoms compared with healthy controls (5.2 ±
5.2 vs. 2.5 ± 2.4, t(35) = 2.144, p = 0.039). There were no
differences between TTC patients and HF patients regard-
ing the severity of depressive symptoms (HF: 6.7 ± 3.9,
t(35) = –1.501, p = 0.142). Moderate to severe depression
(PHQ-9 ≥ 10) was reported by 3 (16.7 %) TTC patients,
0 of the healthy controls and 4 (21.1 %) HF patients (p =
0.118).
Perceived stress levels were higher in TTC compared
with healthy controls (15.0 ± 6.6 vs. 11.4 ± 5.1) although
this difference did not meet the cut-off criteria for statistical
significance (t(34) = 1.854, p = 0.072). No differences were
observed between TTC patients and HF patients (HF: 16.7 ±
6.6, t(34) = –0.704, p = 0.486).
General anxiety levels were not markedly higher in TTC
patients compared with healthy controls (3.3 ± 3.3 vs. 1.9 ±
1.9, t(35) = 1.401, p = 0.170) or HF (HF: 3.8 ± 4.6, t(35) =
0.076, p = 0.940).
TTC and illness-related anxiety
Illness-related anxiety levels were higher in TTC patients
compared with healthy controls (2.1 ± 1.7 vs. 0.7 ± 1.3,
t(32) = 3.037, p = 0.005) (Fig. 1). Analyses per item in-
dicated that this association was mainly carried by health
anxiety-related concerns: i.e., ‘Do you worry a lot about
your health’ (p = 0.002) and ‘Do you feel that you are
bothered by many different symptoms’ (p = 0.004). There
were no differences between TTC patients and HF patients
regarding illness-related anxiety (HF: 2.6 ± 2.1, t(33) =
–0.588, p = 0.561).
Personality factors in TTC versus controls
As shown in Table 2, patients with TTC had significantly
lower levels of openness compared with healthy controls
(34.2 ± 4.3 vs. 38.2 ± 5.6, t(34) = –2.416, p = 0.021). None
of the other NEO-based personality traits were significantly
different between TTC patients and healthy controls and no
differences were observed between TTC patients and HF
patients (Table 2).
Regarding type D personality, the subscales negative af-
fectivity and social inhibition did not differ between TTC
patients and the control groups and no differences between
groups were observed in the model including negative af-
fectivity (p = 0.210), social inhibition (p = 0.948) and their
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Neuroticism 31.0±8.1 29.1±6.8 0.275 31.5±8.5 0.883
Extraversion 40.0±7.1 40.0±6.4 0.985 38.8±6.6 0.583
Openness 34.2±4.3 38.2±5.6 0.021 32.7±4.6 0.343
Conscientiousness 46.3±5.1 46.0±5.5 0.972 44.3±5.7 0.290
Agreeableness 45.4±4.3 44.4±4.3 0.513 43.5±5.4 0.258
Type D
Negative affectivity 7.1±6.2 5.5±4.8 0.379 9.4±8.6 0.377
Social inhibition 8.2±7.0 7.9±7.5 0.878 7.5±6.6 0.737
Interaction NA x SI 0.36±1.2 0.34±0.6 0.937 0.40±1.5 0.936
TCC takotsubo cardiomyopathy, HF heart failure, NA negative affectivity, SI Social Inhibition, Interaction, based on z-scores
Table 3 Associations between psychological measures
1 2 3 4 5 6 7 8 9 10
1. PHQ-9 1.0
2. GAD-7 0.598***
3. PSS-10 0.628** 0.636***
4. WI-7 0.491*** 0.398** 0.468***
5. Neuroticism 0.587*** 0.594*** 0.737*** 0.334*
6. Extraversion –0.325* –0.221 –0.337* –0.194 –0.409**
7. Openness –0.433** –0.273* –0.465*** –0.323* –0.318* 0.117
8. Conscientiousness –0.390*** –0.147 –0.431** –0.097 –0.357** 0.363** 0.020
9. Agreeableness –0.166 –0.080 –0.365** –0.338* –0.325* 0.326* 0.057 0.396*
10. Negative affec-
tivity
0.616*** 0.591*** 0.633*** 0.376** 0.693*** –0.488** –0.263 –0.318* –0.330*
11. Social inhibition 0.259 0.163 0.248 0.122 0.304* –0.737*** –0.149 –0.239 –0.126 0.367**
PHQ Patient Health Questionnaire, GAD-7 the 7-item General Anxiety Disorder scale, PSS-10 10-item Perceived Stress Scale, WI-7 Whiteley-7
scale
***p < 0.001; **p < 0.01; *p < 0.05
interaction (p = 0.986). Dichotomised type D personality
criteria were met by 2 (11.8 %) TTC patients, 3 (15.8 %)
healthy controls and 3 (15.8 %) HF patients (p = 0.926).
Multivariate analyses
MANOVA including measures of depressive symptoms,
perceived stress, general anxiety and illness-related anxi-
ety revealed a significant difference among groups (Wilks’
Lambda = 0.656, F(8,92) = 2.699, p = 0.010, eta2 = 0.190)
and this remained significant after adjusting for age and sex
(p = 0.018). MANOVA-based group comparisons for the
personality factors were consistent with the aforementioned
bivariate analyses, revealing no significant main effect for
patient group (Wilks’ Lambda = 0.739, F(12,94) = 1.276,
p = 0.246, eta2 = 0.140; age- and sex-adjusted p = 0.532,
eta2 = 0.109).
The psychological measures were significantly interre-
lated as shown in Table 3. MANOVA revealed that TTC
patients continued to have elevated illness-related anxiety
levels compared with healthy controls when adjusting for
personality factors, age and sex (p = 0.031), whereas the as-
sociation between TTC and depression was not significant
in the personality factor-adjusted model (p = 0.432).
Discussion
Patients with TTC displayed higher levels of depres-
sive symptoms and illness-related anxiety compared with
healthy controls. General anxiety and perceived stress were
not significantly higher in TTC patients. TTC patients also
displayed less openness compared with healthy controls,
but no other differences were found regarding personality
factors. TTC patients did not differ from HF patients on
any of the psychological measures. These findings suggest
the possibility that the unpredictable nature of TTC and the
lack of a sustained underlying cardiac disease process may
Neth Heart J (2016) 24:530–537 535
result in increased illness-related anxiety and depressive
symptoms in TTC patients.
The finding that patients with TTC have more illness-re-
lated anxiety compared with healthy controls is novel and
consistent with observations in other atypical cardiac con-
ditions. Illness-related anxiety and hypochondriasis predict
persistent symptoms in unexplained chest pain [30]. Prior
studies have reported that TTC [19] and other ‘atypical’
cardiac conditions (non-cardiac chest pain) [31] are asso-
ciated with general anxiety and/or anxiety disorders. The
present investigation showed elevated illness-related anxi-
ety whereas general anxiety was not substantially elevated
in TTC. Item analysis of the Whiteley Index indicated that
the differences between TTC patients versus controls were
mainly carried by illness-related concerns and not an in-
ability to be reassured by physician diagnosis. Increases
in levels of psychological distress from admission to one-
year follow-up have been found in TTC patients compared
with patients with myocardial infarction, despite the im-
provements in left ventricular function in TTC [20]. The
dissociation between echocardiographically determined left
ventricular function and symptoms has also been observed
in a large sample of general practice patients [32]. These
findings may indicate that TTC is followed by increased
health concerns over time that may require intervention in
selected patients.
Consistent with previous studies, we observed elevated
depression levels in TTC. The prevalence of depression dis-
order prior to TTC ranged between 21 and 36 % in prior
studies [18] and was 33 % in the present group of TTC
patients. In the present study, levels of depressive symp-
toms in the post-TTC period were comparable with those
reported by the HF comparison group. These findings indi-
cate that TTC is associated with psychological burden well
after the acute TTC episode has resolved. It is possible that
the integration between the central nervous system and the
autonomic nervous system is impaired in TTC, including
dysregulation of the central autonomic network such as the
medial prefrontal cortex and the insula [33]. This dysregu-
lation may potentially explain the observed elevated mental
stress-induced catecholamine response in TTC combined
with a blunted emotional arousal response [22]. Post-TTC
depressive symptoms and the bio-behavioural correlates of
TTC may also interfere with employability, as patients with
TTC were less often employed compared with healthy con-
trols.
Of the personality factors examined in this study, we
found that TTC patients reported lower levels of openness
compared with healthy individuals, but no other differences
were found regarding personality factors. The low level of
openness in TTC fits our prior observation in this study of
blunted emotional arousal responses to mental stress [22].
In contrast to prior observations, no associations between
TTC and type D personality were found, which may in part
reflect the very high prevalence of type D in the study by
Compare et al. (76 % of TTC patients with and 43 % of
TTC patients without an emotional trigger) [21] compared
with 11.8 % in the present sample. The role of emotional
triggers that precede TTC in the subsequent development
or maintenance of distress-related psychological measures
requires additional research with larger samples that allow
sub-group and covariate-adjusted analyses.
Limitations of this study include the following. The sam-
ple size of this study is small which limited the number of
covariates that could be used in the multivariate models.
The TTC patients also had a less favourable cardiovascular
risk profile, particularly hypertension, but also diabetes and
smoking status and lower education compared with healthy
controls. It is therefore possible that these factors con-
founded the observed association between TTC and psy-
chological measures. The healthy control group was also
younger than the TTC group, but statistical adjustment for
age had minimal effect on the results. In addition, the time
between the acute TTC event and study participation dif-
fered within the TTC patients, which may have resulted
in biases, although no significant correlations were found
between the time since TTC with any of the psychological
measures. Selective survival of TTC patients with relatively
low psychological burden may have attenuated the observed
differences. There are also several strengths to this investi-
gation including the novelty of the assessment of multiple
psychological measures, including illness-related anxiety
and personality factors in this unique patient group.
In conclusion, levels of illness-related anxiety and de-
pressive symptoms were elevated in TTC patients compared
with healthy controls. These differences were not explained
by stable personality factors. Additional research is needed
to determine the prognostic value of psychological meas-
ures, and optimal treatment modules need to be developed
to reduce illness-related anxiety and depressive symptoms
in patients with TTC.
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